EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte StudieOpen Access · CC BY 4.0

Risk factors for spontaneous abortion following hepatitis E vaccination during and shortly before pregnancy: Further analysis from a cluster-randomized trial

Asma Binte Aziz iD, Faisal Ahmmed, Kassa Haile, Kelvin Kering, Susanne Dudman iD, Cathinka Halle Julin, Joakim Øverbø, Ashraful Islam Khan, Afroza Akter, Beatrice Atieno Ongadi iD, Benjamin Ngugi, Cecilia Kathure Mbae und 20 weitere

PLOS One · 10.04.2026 · 21 (4) · e0345974

DOI: 10.1371/journal.pone.0345974 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift PLOS One, online erschienen am 10.04.2026. Verfasst von Asma Binte Aziz und 31 weiteren Autor:innen. Beteiligte Einrichtung: International Vaccine Institute, Seoul, Republic of Korea. Hauptthemen laut MEDLINE: Abortion, Spontaneous, Hepatitis E, Viral Hepatitis Vaccines, Vaccination. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 24 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Norges ForskningsrÃ¥d.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

A recent randomized trial of Hepatitis E Vaccine (HEV239) found an elevated risk of spontaneous abortion (SAB) in women given HEV239 during or within ninety days before pregnancy. Here we present additional analyses to better understand this risk.

Methods

We investigated whether maternal risk profiles of SAB or gestational age at SAB differed between women receiving HEV239 versus control Hepatitis B vaccine (HBV). We also assessed whether HEV239-vaccinated women who experienced SABs had distinct short-term adverse reactions compared to HEV239-vaccinated women who had live births, exploring potential inflammatory mechanisms. Finally, we assessed maternal exposure to HEV239 in narrowly defined pre-last menstrual period (LMP) windows to more precisely demarcate pre-LMP at which HEV-239 vaccination was associated with an elevated risk of SAB. Chi-square tests and Mann-Whitney U tests were performed for bivariate comparisons. Poisson models were used for multivariable analyses.

Findings

Baseline maternal risk factors for SAB (age, body mass index, parity, and histories of SAB, hypertension, or diabetes) were similar between the SABs in HEV239 and HBV groups. Median gestational age at SAB was comparable (10.5 weeks [IQR 10-13] for HEV239 vs. 11 weeks [IQR 9-12.2] for HBV, p = 0.783). No increased short-term adverse events (pain: 9% vs. 9%; fever: 2% vs. 1%) were observed among HEV239 recipients who experienced SABs compared to those who did not. An elevated risk of SAB was observed in HEV239 recipients vaccinated 31–60 days pre-LMP (Relative Risk 4.3 [95% CI 1.3–19.3], p = 0.026).

Interpretation

Our analyses did not uncover associations pointing to a biological mechanism underlying the original observation of an increased SAB rate connected to HEV239 vaccination shortly before or during pregnancy. Targeted studies such as placental examinations and genetic testing are needed to investigate potential mechanisms.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Abortion, SpontaneousHepatitis EViral Hepatitis VaccinesVaccinationHepatitis E virusHumansFemalePregnancyRisk FactorsAdultGestational Age

Substanzen

Viral Hepatitis Vaccines

Autor:innen und Institutionen

  • International Vaccine Institute, Seoul, Republic of Korea.
  • International Centre for Diarrhoeal Disease Research, Dhaka, Bangladesh.
  • Institute of Clinical Medicine, University of Oslo, Norway.
  • Armauer Hansen Research Institute, Addis Ababa, Ethiopia.
  • Kenya Medical Research Institute (KEMRI), Nairobi, Kenya.
  • Oslo University Hospital, Oslo, Norway.

ORCID-Profile: Asma Binte Aziz, Susanne Dudman, Beatrice Atieno Ongadi, Natasha Y Rickett, Sadia Isfat Ara, Suman Kanungo

Förderung

  • Norges ForskningsrÃ¥d

Zitieren

APA

Aziz, A. B., Ahmmed, F., Haile, K., Kering, K., Dudman, S., Julin, C. H., Øverbø, J., Khan, A. I., Akter, A., Ongadi, B. A., Ngugi, B., Mbae, C. K., Mesfin, E., Chowdhury, F., Khanam, F., Lee, J. E., Im, J., Bundi, M. M., Firoj, M. G., …, & Clemens, J. D. (2026). Risk factors for spontaneous abortion following hepatitis E vaccination during and shortly before pregnancy: Further analysis from a cluster-randomized trial. PLOS One, 21(4), e0345974. https://doi.org/10.1371/journal.pone.0345974

Vancouver

Aziz AB, Ahmmed F, Haile K, Kering K, Dudman S, Julin CH, et al. Risk factors for spontaneous abortion following hepatitis E vaccination during and shortly before pregnancy: Further analysis from a cluster-randomized trial. PLOS One. 2026;21(4):e0345974. doi:10.1371/journal.pone.0345974

BibTeX
@article{Aziz2026,
  author = {Aziz, Asma Binte and Ahmmed, Faisal and Haile, Kassa and Kering, Kelvin and Dudman, Susanne and Julin, Cathinka Halle and Øverbø, Joakim and Khan, Ashraful Islam and Akter, Afroza and Ongadi, Beatrice Atieno and Ngugi, Benjamin and Mbae, Cecilia Kathure and Mesfin, Edlawit and Chowdhury, Fahima and Khanam, Farhana and Lee, Joo-Young Esther and Im, Justin and Bundi, Martin Mwebia and Firoj, Md Golam and Islam, Md Taufiqul and Mwangi, Moses and Rickett, Natasha Y and Ara, Sadia Isfat and Behute, Meseret Gebre and Park, Se Eun and Agampodi, Suneth and Kariuki, Samuel and Kanungo, Suman and Kim, Deok Ryun and Qadri, Firdausi and Zaman, Khalequ and Clemens, John D},
  title = {Risk factors for spontaneous abortion following hepatitis E vaccination during and shortly before pregnancy: Further analysis from a cluster-randomized trial},
  journal = {PLOS One},
  year = {2026},
  volume = {21},
  number = {4},
  pages = {e0345974},
  doi = {10.1371/journal.pone.0345974}
}
Kostenlos starten →